drugset / Trial / NCT00135655

A Study of Denufosol Tetrasodium Intravitreal Injection in Subjects With Post Cataract Extraction Macular Edema

NCT00135655 ↗

Phase 2 Withdrawn Merck Sharp & Dohme LLC
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to investigate the safety and tolerability of three dose strengths of the study drug in subjects with post cataract extraction macular edema.

Timeline

Start
2005-08
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject denufosol Other / unclassified — Intravitreal

Indications